FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+24.5%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$782M
AUM Growth
+$782M
(+18%)
Cap. Flow
-$7.32M
Cap. Flow
% of AUM
-0.94%
Top 10 Holdings %
Top 10 Hldgs %
54.41%
Holding
76
New
5
Increased
15
Reduced
30
Closed
7
Top Buys
| 1 |
Tandem Diabetes Care
TNDM
|
$7.88M |
| 2 |
Viatris
VTRS
|
$6.92M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$6.73M |
| 4 |
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
|
$6.01M |
| 5 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$5.85M |
Top Sells
| 1 |
Agios Pharmaceuticals
AGIO
|
$10.8M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$9.87M |
| 3 |
Bristol-Myers Squibb
BMY
|
$6.77M |
| 4 |
Ionis Pharmaceuticals
IONS
|
$4.89M |
| 5 |
Takeda Pharmaceutical
TAK
|
$4.87M |
Sector Composition
| 1 | Healthcare | 72.61% |
| 2 | Communication Services | 8.79% |
| 3 | Industrials | 1.3% |
| 4 | Energy | 0.94% |
| 5 | Financials | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MODN
1
DELISTED
MODEL N, INC.
MODN
| $68.8M | 8.79% | 1,960,725 -9,319 | -0.5% | -$327K |
|
|
OXFD
2
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $67.7M | 8.66% | 4,081,055 +361,764 | +10% | +$6.01M |
|
3
KORU Medical Systems
KRMD
$195M
| $47.1M | 6.02% | 7,218,014 +37,997 | +0.5% | +$248K |
|
4
NeoGenomics
NEO
$1.13B
| $39.1M | 5% | 1,336,949 +17,203 | +1% | +$503K |
|
|
MYOK
5
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $38.8M | 4.96% | 531,884 -2,060 | -0.4% | -$150K |
|
6
Omnicell
OMCL
$1.5B
| $37.1M | 4.74% | 453,504 -2,233 | -0.5% | -$182K |
|
7
AtriCure
ATRC
$1.84B
| $36.2M | 4.62% | 1,112,698 +6,989 | +0.6% | +$227K |
|
8
Insmed
INSM
$28.8B
| $30.9M | 3.95% | 1,293,548 -1,195 | -0.1% | -$28.5K |
|
9
Halozyme
HALO
$8.56B
| $30.2M | 3.85% | 1,700,782 +18,037 | +1% | +$320K |
|
|
XENT
10
DELISTED
Intersect ENT, Inc
XENT
| $29.9M | 3.82% | 1,199,169 -16,953 | -1% | -$422K |
|
|
IMMU
11
DELISTED
Immunomedics Inc
IMMU
| $26.3M | 3.37% | 1,245,243 -5,293 | -0.4% | -$112K |
|
12
Heron Therapeutics
HRTX
$207M
| $25.4M | 3.25% | 1,081,159 -9,951 | -0.9% | -$234K |
|
|
PTLA
13
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $24.1M | 3.08% | 1,008,957 +244,861 | +32% | +$5.85M |
|
|
SPNE
14
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $21.9M | 2.8% | 1,826,404 -26,152 | -1% | -$314K |
|
15
Codexis
CDXS
$246M
| $19M | 2.42% | 1,186,113 -12,339 | -1% | -$197K |
|
|
16
Teva Pharmaceuticals
TEVA
$21.1B
| $16.2M | 2.07% | 1,656,171 +686,941 | +71% | +$6.73M |
|
|
17
Tandem Diabetes Care
TNDM
$845M
| $16M | 2.05% | 268,574 +132,246 | +97% | +$7.88M |
|
18
SI-BONE Inc
SIBN
$719M
| $14.7M | 1.88% | 685,131 +39,149 | +6% | +$842K |
|
|
19
Ionis Pharmaceuticals
IONS
$6.79B
| $14.7M | 1.88% | 243,691 -80,958 | -25% | -$4.89M |
|
|
VAPO
20
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $13.9M | 1.78% | 1,147,010 +123,276 | +12% | +$1.5M |
|
21
Xencor
XNCR
$580M
| $11.5M | 1.47% | 333,855 -1,589 | -0.5% | -$54.6K |
|
22
Veracyte
VCYT
$2.39B
| $11.4M | 1.46% | 409,077 -1,848 | -0.4% | -$51.6K |
|
|
23
Viatris
VTRS
$12.3B
| $10.7M | 1.37% | 532,783 +344,493 | +183% | +$6.92M |
|
|
TRHC
24
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $10.2M | 1.3% | 209,689 +14,342 | +7% | +$698K |
|
|
AMRN
25
Amarin Corp
AMRN
$311M
| $9.83M | 1.26% | 458,289 -460,557 | -50% | -$9.87M |
|